Medgenics, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 7,297 5,431 5,052 3,052
Sales, General and Admin. 10,521 7,197 4,924 1,828
Non-Recurring Items - - - -
Other - - - -
Operating Income (17,818) (12,628) (9,976) (3,354)
Income From Continuing Operations
Add'l Income/Expense Items 726 5 2,097 873
Earnings Before Interest and Tax (17,092) (12,623) (7,879) (2,481)
Interest Expense 20 2,429 214 1,664
Earnings Before Tax (17,112) (15,052) (8,093) (4,145)
Income Tax 17 19 3 2
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (17,129) (15,071) (8,096) (4,147)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (17,129) (15,071) (8,096) (4,147)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (17,129) (15,071) (8,096) (4,147)